Shibasaur – the Newest Crypto that is disrupting the DeFi space using innovative contract functions

NY, USA, 23 Aug 2021, ZEXPRWIRE, DeFi, or “decentralized finance,” is a term used to describe the variety of financial applications used on the blockchain geared towards disrupting centralized financial systems. Recently, DeFi coins such as SHIBA INU and SAFEMOON have changed simple transfers into more complex financial use cases Read more

August 23, 2021|

MobilityGuru launches a new altcoin to make blockchain technology more inclusive for people with disabilities

London, UK, 23 Aug 2021, ZEXPRWIRE, MobilityGuru is a blockchain-based project born out of the belief that every human being living with a disability deserves access to inclusive, reliable and competitively priced online marketplace. With an already running website and over millions of dollars’ worth of listed services and products, Read more

August 23, 2021|

USWAP – the DEX for the new DeFi and NFT era

LONDON, UK, 22 Aug 2021, ZEXPRWIRE, USWAP is a DEX (decentralized exchange) which is deployed on the TRON Blockchain. It is a modified and improved version of the UNISWAP V2 model which is deployed on the Ethereum network. Decentralized exchanges are part of the DeFi (decentralized finance) revolution which endeavours Read more

August 22, 2021|

DIKE.FINANCE – A TRANSPARENT, PRIVATE, AND SECURED-CREDIT DECENTRALIZED TRADING PLATFORM

London, UK, 22 Aug 2021, ZEXPRWIRE, For investors, centralized trading platforms are no longer a preferable option. As a result of rising vulnerabilities caused by hackers, the credibility of these platforms is diminishing. In this circumstance, the idea of a decentralized trading platform that adapts transparency, security, and safety for Read more

August 22, 2021|

Bonus BioGroup Receives Approval to Expand Phase-II Clinical Trials for its COVID-19 Treatment to Medical Centers Across Israel

TEL AVIV, ISRAEL, 22 Aug 2021, ZEXPRWIRE, Bonus BioGroup LTD or "the Company" (BONS.TA), an Israeli clinical-stage biotechnology company, has received official approval from the Israeli Ministry of Health to expand its phase II clinical trials for its MesenCure treatment to health centers and hospitals nationwide. MesenCure leverages advances in Read more

August 22, 2021|
Go to Top